Corporacion Parc Tauli
180
11
12
95
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
4.4%
8 terminated/withdrawn out of 180 trials
92.2%
+5.7% vs industry average
8%
15 trials in Phase 3/4
1%
1 of 95 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (180)
Moderate-vigorous Intermittent Physical Activity (M-VILPA) in Stroke
Role: collaborator
Shared Decision Making and Satisfaction With the Diagnostic-therapeutic Process in the Shared Decision Making and Satisfaction With Colorectal Cancer Screening. The CyDESA Study
Role: lead
Living With Long COVID: LONGCOVID-EXPERIENCE
Role: lead
Effectiveness of the Decolonization Circuit of S. Aureus, Reducing Infection in Primary Arthroplasty of the Lower Limb
Role: lead
Knowledge and Needs of Nursing in Relation to the Treatment Complex Wounds
Role: lead
Assessing Fluid-responsiveness Using Non-invasive Hybrid Diffuse Optics on Peripheral Muscle
Role: lead
The Post Intensive Care Syndrome Follow-up and Management Study: The ICU Recovery Answers Project
Role: lead
Medical Device for Oxaliplatin-Induced Neuropathy in Gastrointestinal Cancer Patients
Role: lead
Preventing Suicide With Digital Phenotyping and Pharmacogenetics-Based Interventions
Role: collaborator
Rehabilitation Gaming System for Intensive Care Units
Role: collaborator
Conservative Management in Primary Spontaneous Pneumothorax: a Multicenter Randomized Non-inferiority Study
Role: lead
Metabolic Cluster Analysis in Septic Shock Patients
Role: lead
Mathematical Analysis of Signals and Clinical Parameters Provided by Non-invasive Home Ventilation Devices
Role: lead
Evolution of Physical and Emotional Distress in ICU
Role: lead
Manual Therapy and Gastroesophageal Reflux Disease in Patients With Hiatal Hernia
Role: collaborator
EEG-based Neurofeedback to Improve Emotion Regulation in Major Depressive Disorder: A Randomized Clinical Trial
Role: lead
Coexistence HBsAg/HBcAC, Clinical Characterístics & Outcomes
Role: lead
Neural Biomarkers in Fragile X Syndrome
Role: collaborator
Functional Connectome in Prader-Willi Syndrome: Neuroimaging and AI to Assess Therapeutic Impact
Role: lead
Effect of Deep Propioceptive Stimulation in Prader-Willi Syndrome
Role: lead